Skip to main content
. 2019 Dec;60(12):1705–1712. doi: 10.2967/jnumed.119.225771

TABLE 1.

Definitions of Screening Strategies

Screening strategy designation Screening strategy description Definition of positive imaging result After positive imaging results After negative imaging results
1 Standard biopsy N/A (no imaging) N/A; always standard biopsy N/A; always standard biopsy
2 mpMRI alone (Likert scores) Likert 4–5 Combined biopsy Standard biopsy
3 mpMRI alone (PI-RADS scores) PI-RADSv2 3–5 Combined biopsy Standard biopsy
4 18F-choline PET/mpMRI (Likert scores) Likert 5 mpMRI lesion or Likert 3–4 mpMRI lesion with 18F-choline TBR of ≥1.58* Combined biopsy Standard biopsy
5 18F-choline PET/mpMRI (PI-RADS scores) PI-RADS 5 mpMRI lesion or PI-RADS 3–4 mpMRI lesion with 18F-choline TBR of ≥1.58 Combined biopsy Standard biopsy
6 mpMRI alone (Likert scores) Likert 4–5 Combined biopsy No biopsy
7 mpMRI alone (PI-RADS scores) PI-RADS 3–5 Combined biopsy No biopsy
8 18F-choline PET/mpMRI (Likert scores) Likert 5 mpMRI lesion or Likert 3–4 mpMRI lesion with 18F-choline TBR of ≥1.58 Combined biopsy No biopsy
9 18F-choline PET/mpMRI (PI-RADS scores) PI-RADS 5 mpMRI lesion or PI-RADS 3–4 mpMRI lesion with 18F-choline TBR of ≥1.58 Combined biopsy No biopsy
*

TBR threshold was defined in study by Piert et al. (8).

N/A = not applicable.